Young Barley Leaf for Constipation in Long-Term Care
أوراق الشعير الفتية للإمساك في الرعاية طويلة الأمد
Journal: Geriatric nursing (New York, N.Y.)
University: Not specified
Study Type: cohort
Evidence Level: low
Participants: 28
Published:
⚠️ Warning: This is a preliminary study (animal/cell) and has not been proven in humans.
30-Second Summary
This quasi-experimental pilot study evaluated the feasibility and short-term effects of young barley leaf (YBL) supplementation on functional constipation among 28 long-term care residents. Results showed an increase in defecation frequency during the second week of supplementation.
1-Minute Summary
This quasi-experimental pilot study investigated the effects of young barley leaf (YBL) supplementation on 28 long-term care residents suffering from functional constipation based on Rome IV criteria. Participants received 3 g of YBL twice daily for two weeks following a baseline observation period. Daily records tracked defecation frequency, laxative use, and bowel sounds, alongside select biochemical and gut hormone assessments. The intervention was associated with an increase in defecation frequency during the second week of the supplementation period compared to baseline. These preliminary findings suggest potential short-term bowel-related changes, though further controlled research is required.
3-Minute Summary
This quasi-experimental pilot study investigated the feasibility and short-term bowel-related changes of young barley leaf (YBL) supplementation in long-term care residents suffering from functional constipation. Functional constipation is a highly prevalent, debilitating issue in geriatric populations, often exacerbated by immobility, low fiber intake, polypharmacy, and cognitive impairment. Conventional management heavily relies on laxatives, which can cause electrolyte imbalances, abdominal cramping, and dependency over prolonged periods. Therefore, exploring safe, non-pharmacological dietary supports like fiber-rich plant supplements is of significant clinical interest. Conducted in a single long-term care facility, the study enrolled twenty-eight residents who met the stringent Rome IV criteria for functional constipation. The trial design incorporated a one-week baseline observational period followed by a two-week intervention phase during which participants received 3 grams of YBL twice daily (totaling 6 grams per day). Care staff and investigators meticulously recorded daily parameters, including defecation frequency, the use of rescue medication (bisacodyl), and abdominal bowel sounds via auscultation. Additionally, selected biochemical parameters and specific gut hormone levels were measured at baseline and post-intervention to gather preliminary mechanistic and safety insights. The findings demonstrated a statistically significant increase in defecation frequency during the second week of YBL supplementation compared to the baseline period. This suggests a cumulative or delayed physiological response typically observed when introducing dietary fiber interventions to chronic constipation sufferers, as the colonic microbiota and transit time require a stabilization window. Furthermore, the intervention showed favorable trends regarding the reduction of rescue laxative use and good overall gastrointestinal tolerance among the fragile elderly cohort. Biochemical markers and safety parameters remained stable, highlighting the short-term feasibility and safety of administering YBL in a nursing home setting. Despite the promising outcomes, the study's methodological constraints—principally the lack of a control group, small sample size, and short duration—mean that these results must be interpreted as preliminary. Larger, randomized controlled trials are required to confirm efficacy, optimize dosing regimens, and definitively establish the long-term clinical utility of young barley leaf for geriatric constipation management.
Full Analysis
1. Introduction and Background Functional constipation is a highly prevalent gastrointestinal disorder among older adults residing in long-term care (LTC) facilities. The etiology is multifactorial, involving age-related physiological alterations such as decreased colonic motility, diminished rectal sensitivity, pelvic floor dyssynergia, alongside extrinsic factors like polypharmacy, low dietary fiber intake, fluid restriction, and sedentary lifestyles. Chronic constipation significantly impairs the quality of life of LTC residents and can lead to severe complications, including fecal impaction, stercoral ulceration, bowel perforation, and delirium. While pharmacological agents (osmotic and stimulant laxatives) are standard, their long-term use is frequently complicated by adverse effects such as electrolyte disturbances, laxative dependency, and abdominal discomfort. Consequently, investigating safe, non-pharmacological dietary adjuncts that improve bowel function without systemic toxicity is a clinical priority. 2. Methodology and Study Design This study utilized a one-group quasi-experimental pilot design conducted within a specialized long-term care facility. A total of 28 residents meeting the Rome IV diagnostic criteria for functional constipation were enrolled. The trial structure consisted of a 1-week baseline observational run-in period followed by a 2-week active intervention phase. Participants were administered young barley leaf (YBL) powder at a dosage of 3 grams twice daily (totaling 6 g/day), dissolved in water or warm beverages. - Data Collection: Care staff and study investigators performed daily logs of defecation frequency, consistency (using the Bristol Stool Form Scale implicitly or explicit categorization), use of rescue medications (specifically bisacodyl), and abdominal auscultation for bowel sounds. - Biochemical & Hormonal Evaluation: Blood samples were collected at baseline and at the conclusion of the 2-week intervention to monitor select biochemical safety parameters and systemic gut hormone profiles, serving as physiological contextual markers. - Statistical Analysis: Changes across time points were evaluated using paired parametric or non-parametric tests, comparing the baseline metrics against week 1 and week 2 of the supplementation phase. 3. Detailed Results and Findings The primary outcome measure—defecation frequency—demonstrated a statistically significant increase during the second week of YBL supplementation compared to the pre-intervention baseline period. The delay in achieving statistical significance until week 2 aligns with the known physiological adaptation timeline of the human gastrointestinal microbiome and colonic transit adjustments following increased dietary fiber and bioactive phytochemical intake. Secondary parameters, including rescue bisacodyl utilization, showed a downward trend, suggesting a potential substitution effect where dietary support reduces the reliance on harsh chemical stimulants. Bowel sounds evaluated via auscultation indicated enhanced peristaltic activity. Biochemical and hormonal parameters remained within safe clinical thresholds, confirming that short-term YBL administration did not elicit adverse metabolic or electrolyte imbalances in this vulnerable demographic. 4. Mechanistic Context and Bioactive Profile of Young Barley Leaf Young barley leaf is rich in dietary fibers (both soluble and insoluble), antioxidant enzymes (such as superoxide dismutase), flavonoids, vitamins, and minerals. Soluble fibers act as prebiotics, undergoing fermentation by colonic bacteria to produce short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate. SCFAs lower luminal pH, stimulate colonic blood flow, enhance electrolyte absorption, and directly promote peristaltic contractions via enteric nervous system activation. Insoluble fiber increases fecal bulk and mechanical distension, triggering the mechanoreceptors in the gut wall that initiate the defecation reflex. Furthermore, the micronutrient and polyphenol profile of YBL may exert anti-inflammatory effects on the enteric mucosa, supporting overall gut homeostasis. 5. Methodological Limitations Despite the encouraging signals, several critical limitations inherent to the pilot design must be acknowledged: - Lack of a Control Group: The absence of a parallel control group or placebo arm leaves the findings vulnerable to confounding factors, the Hawthorne effect (altered behavior due to observation), and spontaneous symptom fluctuation. - Small Sample Size: With only 28 participants, the statistical power is limited, and the findings cannot be generalized to the broader geriatric population. - Short Duration: A 2-week intervention window captures short-term feasibility and immediate bowel response but is insufficient to evaluate long-term sustainability, potential tolerance development, or compliance issues over months. - Confounding Variables: Dietary intake outside the supplement, minor variations in daily hydration, and concurrent medications were challenging to fully standardize in an open LTC environment. 6. Conclusion and Future Directions This pilot trial provides preliminary evidence supporting the feasibility, short-term safety, and potential bowel-regulating efficacy of young barley leaf supplementation in long-term care residents with functional constipation. The significant increase in defecation frequency by week 2 warrants more rigorous investigation. Future research should prioritize large-scale, double-blind, randomized controlled trials (RCTs) with extended follow-up periods to definitively validate efficacy, determine optimal dosing parameters, and assess long-term impacts on quality of life and healthcare utilization in geriatric cohorts.Health Implications
Incorporating fiber-rich plant elements and adequate hydration into daily routines serves as a foundational approach to supporting gastrointestinal motility and maintaining regular bowel patterns. For older adults, gentle and consistent dietary adjustments help sustain a healthy gut microbiome and reduce reliance on pharmacological laxatives, thereby promoting long-term digestive well-being.
Key Findings
- Defecation frequency increased significantly during the second week of YBL supplementation compared to baseline.
- YBL supplementation was well-tolerated as a non-pharmacological dietary support in a long-term care setting.